About Erik Newman, MD

Dr. Erik T. Newman is a fellowship-trained orthopaedic oncology surgeon who specializes in the care of children and adults with benign and malignant musculoskeletal tumors, metastatic bone disease, and complex pelvic and limb reconstructions.  

Dr. Newman received his Bachelor of Arts from Dartmouth College (summa cum laude, Phi Beta Kappa) and his medical degree from Duke University. He completed residency in orthopaedic surgery at the Harvard Combined Orthopaedic Residency Program, where he served as Academic Chief Resident and received the William H. Thomas Award for Excellence in Patient Care and the James H. Herndon Award for Excellence in Teaching and Mentorship. He completed fellowship training in orthopaedic oncology at the Massachusetts General Hospital, Beth Israel Deaconess Medical Center, and Boston Children’s Hospital.

He is a member of the Mass General Sarcoma and Connective Tissue Oncology Center, as well as the Stephan L. Harris Center for Chordoma Care, and is active in teaching medical students, residents, and fellows as an Instructor in Orthopaedic Surgery at Harvard Medical School.

Clinical Interests:



Orthopaedic Oncology Service | Centers for Sarcoma & Chordoma
55 Fruit Street
Yawkey Center for Outpatient Care
Suite 3B
Boston, MA 02114
Phone: 617-643-4947

Medical Education

  • MD, Duke University School of Medicine
  • Residency, Massachusetts General Hospital
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • Orthopaedic Surgery, American Board of Orthopaedic Surgery

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Dr. Newman maintains a strong interest in clinical research. He has presented his research at national conferences and has published in numerous peer-reviewed medical journals. Areas of on-going investigation include functional outcomes after tumor surgery, novel approaches to the surgical management of metastatic bone disease, and diagnosis and treatment of musculoskeletal infection.


  • Newman ET, Lans J, Kim J, Ferrone ML, et al. PROMIS function scores are lower in patient who underwent more aggressive local treatment for desmoid tumors. Clin Orthop Relat Res. 2019 Aug.

    Newman ET, Hornicek F, Schwab JH. Tumors of the sacrum: diagnosis, management, and surgical techniques. Tumors of the Sacrum: Diagnosis and Treatment of Benign and Malignant Tumors. Ed: Ruggiero, P, Angelini, V, Picci, Piero. Springer Int Pub. 2017.

    Newman ET, Herschmiller T, Attarian DE, Vail TP, et al. Risk factors, outcomes, and timing of manipulation under anesthesia after total knee arthroplasty. J Arthroplasty. 2018 Mar.

    Newman ET, Kelly BA, Rodriguez EK. The “Magneto View”: A simple method for obtaining intraoperative axial radiographs of the calcaneus. OJHMS. 2015 June.

    Newman ET, Watters TS, Lewis JS, Jennings JM, et al. Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty. J Bone Joint Surg Am. 2014 Feb.

    Queen RM, Appleton JS, Butler RJ, Newman ET, et al. Total hip arthroplasty surgical approach does not alter postoperative gait mechanics one year after surgery. PM R. 2014 Mar.

    Newman ET, Hug KT, Wellman SS, Bolognesi MP, et al. Custom intramedullary intercalating device for treatment of supracondylar fracture between constrained total knee arthroplasty and well-fixed total hip arthroplasty. Knee. 2014 Mar. 

    Queen RM, Newman ET, Abbey AN, Vail TP, et al. Stair ascending and descending in hip resurfacing and large head total hip arthroplasty patients. J Arthroplasty. 2013 Apr.

Reviews: Comments and Ratings